1. Unmet Parenthood Goals, Health-Related Quality of Life and Apparent Irrationality: Understanding the Value of Treatments for Infertility

   • Chris Skedgel
   • Patricia Cubi-Molla
   • Mireia Jofre-Bonet

   Current Opinion Open access 15 March 2023 Pages: 337 - 344

2. Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

   • Rachel Houten
   • Nigel Fleeman
   • Carlo Palmieri

   Review Article Open access 21 April 2023 Pages: 345 - 358

3. Health Economic Studies of Surfactant Replacement Therapy in Neonates with Respiratory Distress Syndrome: A Systematic Literature Review

   • Tiziana Magni
   • Chiara Ragni
   • Natalia Meshchenkova

   Systematic Review Open access 11 March 2023 Pages: 359 - 371

   

4. The Evaluation of Drug Innovativeness in Italy: Key Determinants and Internal Consistency

   • Claudio Jommi
   • Carlotta Galeone

   Original Research Article Open access 10 February 2023 Pages: 373 - 381

   

5. Impact of Extrapolation Model Choices on the Structural Uncertainty in Economic Evaluations for Cancer Immunotherapy: A Case Study of Checkmate 067

   • Taihang Shao
   • Mingye Zhao
   • Wenxi Tang

   Original Research Article Open access 09 February 2023 Pages: 383 - 392

   

6. Cost Effectiveness of Letermovir for Cytomegalovirus Prophylaxis Compared with Pre-Emptive Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the United States

   • Aryana Sepassi
   • Ila M. Saunders
   • Jonathan H. Watanabe

   Original Research Article Open access 25 February 2023 Pages: 393 - 404

   

7. A Cross-Indication Budget Impact Model of Secukinumab for the Treatment of Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis in Italy

   • Paolo Angelo Cortesi
   • Carla Fornari
   • Lorenzo Giovanni Mantovani

   Original Research Article Open access 16 March 2023 Pages: 405 - 416

   

8. Economic Evaluation Comparing Virtual Reality with Child Life Programming for Non-sedated Pediatric Medical Imaging: A Cost-Consequence Analysis

   • John Jacob
   • Chelsea Stunden
   • Luke Thomas

   Original Research Article Open access 11 April 2023 Pages: 417 - 429

   

9. Cost-Analysis of Subcutaneous vs Intravenous Administration of Natalizumab Based on Patient Care Pathway in Multiple Sclerosis in Spain

   • A. M. Alonso Torres
   • A. G. Arévalo Bernabé
   • I. Oyagüez

   Original Research Article Open access 21 February 2023 Pages: 431 - 441

   

10. Economic Evaluation of Tirbanibulin for the Treatment of Actinic Keratosis in Scotland

    • Amy Dymond
    • Will Green
    • Girish Gupta

    Original Research Article Open access 03 April 2023 Pages: 443 - 454

    

11. Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer

    • Andre Verhoek
    • Parneet Cheema
    • Daniel Moldaver

    Original Research Article Open access 22 February 2023 Pages: 455 - 467

    

12. Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)

    • Owen Alan Edwards Cooper
    • Ola Ghatnekar
    • Jørn Skibsted Jakobsen

    Original Research Article Open access 03 February 2023 Pages: 469 - 477

    

13. Budget Impact of Three Improvement Targets for Compression Therapy for Patients with Deep Venous Thrombosis in The Netherlands

    • Rachel H. P. Schreurs
    • Arina J. ten Cate-Hoek
    • Manuela A. Joore

    Original Research Article Open access 19 April 2023 Pages: 479 - 491

    

14. Cost Analysis of a Transition Care Bundle Compared with Usual Care for COPD Patients Being Discharged from Hospital: Evaluation of a Randomized Controlled Trial

    • Charles Yan
    • Jeff Round
    • Michael K. Stickland

    Original Research Article Open access 11 March 2023 Pages: 493 - 505